Idiopathic Granulomatous Mastitis: A Consensus Report on Treatment and Follow-Up Approaches Based on the Turkish Clinical Classification

医学 中止 肉芽肿性乳腺炎 德尔菲法 疾病 放射性武器 儿科 乳腺炎 内科学 外科 病理 统计 数学
作者
Mustafa Emiroğlu,Kenan Çetin,Kerim Bora Yılmaz,Mehmet Velidedeoğlu,Sadullah Girgin,Alper Akçan,Hüseyin Özgür Aytaç,Murat Akın,Hande Köksal,Neslihan Cabıoğlu,Nuh Zafer Cantürk,Bahadır M. Güllüoğlu
出处
期刊:Breast Care [Karger Publishers]
卷期号:: 1-17
标识
DOI:10.1159/000544967
摘要

Objective: The second consensus study on idiopathic granulomatous mastitis (IGM) aimed to establish treatment options based on the clinical classification proposed in the first consensus, standardize criteria for treatment discontinuation, and develop follow-up protocols. Method: A structured methodology, identical to the first consensus study, was employed. An 11-member working group of breast surgeons experienced in IGM from various clinics across the country was formed. The modified Delphi method was used, with a consensus threshold of 80% agreement. Results: Three voting rounds were conducted to develop the IGM treatment algorithm. In Round 1, observation was established as the first-line option for Type 1 disease (81%) and pregnancy/lactation cases (85%). Round 2 achieved consensus on systemic steroids (SS) as the first-line treatment for Type 3 cases (84%), combination therapies for resistant cases (82%), and reclassification of recurrent cases to guide treatment planning (94%). In Round 3, consensus was reached on the use of immunosuppressive therapy (IMT) for cases where steroids are contraindicated in Type 3 (81%), the use of IMT for resistant cases (93%), avoiding surgery as the first-line option for Type 1 cases (81%), and requiring complete clinical and radiological response before discontinuing treatment (81%). However, no consensus was reached on the first-line treatment for Type 2 disease. Conclusion: This consensus study successfully developed a treatment algorithm for IGM, prioritizing observation for Type 1 disease and cases involving pregnancy or lactation, and recommending systemic steroids (SS) and immunosuppressive therapies for Type 3 cases. The findings underscore the critical importance of achieving complete clinical and radiological remission before discontinuing treatment. However, the lack of consensus on the treatment of Type 2 disease highlights the need for further research into this challenging subtype.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
FashionBoy的应助被OK采纳,获得20
1秒前
等待的小馒头完成签到 ,获得积分10
1秒前
破晓发布了新的文献求助10
1秒前
木维维发布了新的文献求助20
3秒前
4秒前
zoe11发布了新的文献求助100
4秒前
白菜完成签到,获得积分10
6秒前
7秒前
洛洛薇完成签到 ,获得积分10
8秒前
刘艺涵完成签到,获得积分10
8秒前
隐形曼青的应助被耕者天下采纳,获得10
8秒前
sml的应助被太叔开山采纳,获得10
8秒前
bkagyin的应助被12138采纳,获得10
8秒前
10秒前
10秒前
wanci的应助被kela采纳,获得30
11秒前
xing_xing的应助被友好的季节采纳,获得20
11秒前
11秒前
陈业祝关注了科研通微信公众号
11秒前
12秒前
13秒前
bi8bo发布了新的文献求助10
14秒前
小豆包发布了新的文献求助10
15秒前
玉米玉米发布了新的文献求助10
15秒前
太叔开山完成签到,获得积分20
16秒前
鼎元发布了新的文献求助10
16秒前
呵呵哒发布了新的文献求助10
16秒前
lazyp完成签到 ,获得积分10
17秒前
Huihui完成签到,获得积分10
18秒前
19秒前
19秒前
Nature发布了新的文献求助10
19秒前
ding的应助被酒酽春浓采纳,获得10
20秒前
天天快乐的应助被朴实醉柳采纳,获得10
21秒前
21秒前
桐桐的应助被陈业祝采纳,获得10
21秒前
木木夕云发布了新的文献求助10
22秒前
23秒前
科研通AI2S的应助被小九采纳,获得10
24秒前
78888发布了新的文献求助10
25秒前
高分求助中
(应助此贴封号)通过应助OA文献获取积分 10000
Rosenblum, Global Change Biology 800
The Dawn of Philology 520
Organizational Behavior 510
Production Logging: Theoretical and Interpretive Elements 400
A primer on partial least squares structural equation modeling (PLS-SEM) (4th ed.) 310
中国器官捐献和移植发展报告(2024) 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 有机化学 化学工程 内科学 物理 生物化学 复合材料 催化作用 细胞生物学 人工智能 心理学 无机化学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 7822097
求助须知:如何正确求助?哪些是违规求助? 9348933
关于积分的说明 20550282
捐赠科研通 7414844
什么是DOI,文献DOI怎么找? 3333210
关于科研通互助平台的介绍 2479118
邀请新用户注册赠送积分活动 2353610